Serum Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) is Independently Associated with Insulin Resistance, Triglycerides, Lipoprotein(a) Levels but not Low-Density Lipoprotein Cholesterol Levels in a General Population-Reference-Cited by-同舟云学术

Serum Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) is Independently Associated with Insulin Resistance, Triglycerides, Lipoprotein(a) Levels but not Low-Density Lipoprotein Cholesterol Levels in a General Population

Published:2021-04-01 Issue:4 Volume:28 Page:329-337
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Hamamura Hitoshi¹,Adachi Hisashi¹²,Enomoto Mika¹,Fukami Ako¹,Nakamura Sachiko¹,Nohara Yume¹,Morikawa Nagisa¹,Sakaue Akiko¹,Toyomasu Kenta¹,Yamamoto Maki¹,Fukumoto Yoshihiro¹

Affiliation:

1. Department of Internal Medicine, Division of Cardio-Vascular Medicine, Kurume University School of Medicine

2. Department of Community Medicine, Kurume University School of Medicine

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry, medical,Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/jat/28/4/28_56390/_pdf

Reference38 articles.

1. 1) Hasan H, Attlee A, Raigangar V, Madkour M, Awadallah S: Proprotein convertase subtilisin/kexin type 9 (PCSK9) and metabolic syndrome components among young adult females. Diabetes Metab Syndr, 2017; 11 (Suppl 1): S337-S341

2. 2) Baass A, Dubuc G, Tremblay M, Delvin EE, O’Loughlin J, Levy E, Davignon J, Lambert M: Plasma PCSK9 is associated with age, sex, and multiple metabolic markers in a population-based sample of children and adolescents. Clin Chem, 2009; 55: 1637-1645